Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 1 of 7
1  |  2  |  3  |  4  |  5  |  6  |  7

Scientific Advancements
Tuesday, November 5, 2019   (0 Comments - view/add)
AGTC Announces Stargardt Disease as its Second Preclinical Ophthalmology Program and Reports Compell »
AGTC Announces Stargardt Disease as its Second Preclinical Ophthalmology Program and Reports Compelling Preclinical Data S...
Monday, October 28, 2019   (0 Comments - view/add)
Cyclo Therapeutics Prepares for Alzheimer’s Development Program After Success with First Patient »
Cyclo Therapeutics Prepares for Alzheimer’s Development Program After Success with First Patient   ORLANDO, FL...
Tuesday, October 22, 2019   (0 Comments - view/add)
Cyclo Therapeutics Announces Completion of Enrollment in its Phase I Trial to Evaluate Trappsol® Cyc »
Cyclo Therapeutics Announces Completion of Enrollment in its Phase I Trial to Evaluate Trappsol® Cyclo™ for the Treatment...
Tuesday, September 17, 2019   (0 Comments - view/add)
20Lighter Announces Peer-Reviewed Publication of Weight Loss Program Clinical Data »
20Lighter Announces Peer-Reviewed Publication of Weight Loss Program Clinical Data By: 20Lighter, LLC  ...
Monday, September 9, 2019   (0 Comments - view/add)
Nano Discovery Inc. Launches a New Blood Test for Cattle Immune Health Testing »
Nano Discovery Inc. Launches a New Blood Test for Cattle Immune Health Testing   ORLANDO, Fla.--( BUSINESS W...
Friday, September 6, 2019   (0 Comments - view/add)
Ridgeback Biotherapeutics LP announces receipt of Breakthrough Therapy designation from FDA for mAb1 »
Ridgeback Biotherapeutics LP announces receipt of Breakthrough Therapy designation from FDA for mAb114 MIAMI , Sept....
Thursday, September 5, 2019   (0 Comments - view/add)
ZyVersa Therapeutics Advances Development of Lead Inflammasome Inhibitor Candidate, IC 100 »
ZyVersa Therapeutics Advances Development of Lead Inflammasome Inhibitor Candidate, IC 100   IC 100 is a novel...
Thursday, August 29, 2019   (0 Comments - view/add)
OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth »
OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied...
Friday, August 23, 2019   (0 Comments - view/add)
Mayo Clinic and United Therapeutics to increase lungs for transplantation in new building dedicated »
By Kevin Punsky   Mayo Clinic and United Therapeutics to increase lungs for transplantation in new build...
Friday, August 16, 2019   (0 Comments - view/add)
Discovery of anti-opioid pathway offers new route to designing safer pain medications »
Discovery of anti-opioid pathway offers new route to designing safer pain medications   August 16, 2019...
Monday, August 12, 2019   (0 Comments - view/add)
Ridgeback Biotherapeutics LP announces an update on mAb114, an experimental treatment for Ebola »
Ridgeback Biotherapeutics LP announces an update on mAb114, an experimental treatment for Ebola MIAMI , Aug. 12, 2019...
Thursday, August 8, 2019   (0 Comments - view/add)
Scientists discover ‘forgetting’ enzyme that lops brain cell branches »
Scientists discover ‘forgetting’ enzyme that lops brain cell branches JUPITER, Fla. — Aug. 8, 2019 — An enzyme cal...
Tuesday, July 30, 2019   (0 Comments - view/add)
New Startup Biotech Company Plans to Test Promising Herpes Vaccine for Both HSV-1 and HSV-2 »
New Startup Biotech Company Plans to Test Promising Herpes Vaccine for Both HSV-1 and HSV-2 CLEARWATER, Fla. , July 3...
Tuesday, July 23, 2019   (0 Comments - view/add)
AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 P »
AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Stud...
Monday, July 22, 2019   (0 Comments - view/add)
Alz1 Launches the First At-Home Solution to Detect, Help Reduce Risk Factor Associated with Alzheime »
Alz1 Launches the First At-Home Solution to Detect, Help Reduce Risk Factor Associated with Alzheimer’s Disease...
Wednesday, June 26, 2019   (0 Comments - view/add)
Precigen Announces First Patient Dosed in Phase 1/1b Study of PRGN-3006 UltraCAR-T™ in Patients with »
Precigen Announces First Patient Dosed in Phase 1/1b Study of PRGN-3006 UltraCAR-T™ in Patients with Relapsed or Refractor...
Tuesday, June 25, 2019   (0 Comments - view/add)
ILiAD Biotechnologies Announces First Patient Enrolled in BPZE1 Pertussis Vaccine Multicenter Phase »
ILiAD Biotechnologies Announces First Patient Enrolled in BPZE1 Pertussis Vaccine Multicenter Phase 2b Clinical Trial...
Wednesday, June 19, 2019   (0 Comments - view/add)
Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity t »
Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity to Enable Determination...
Thursday, June 13, 2019   (0 Comments - view/add)
GT Biopharma GTB-1550 »
GT Biopharma GTB-1550 Multi-Targeted Bispecific Drug Conjugate Strategically positioned in new class of ADC Drugs...
Thursday, June 6, 2019   (0 Comments - view/add)
RTI Surgical® Reaches 5,000 Implant Milestone for Fortilink® Interbody Fusion Systems with TETRAfuse »
RTI Surgical® Reaches 5,000 Implant Milestone for Fortilink® Interbody Fusion Systems with TETRAfuse® 3D Technology De...
Monday, May 20, 2019   (0 Comments - view/add)
Oragenics, Inc. Provides Development Update of AG013 for Oral Mucositis »
Oragenics, Inc. Provides Development Update of AG013 for Oral Mucositis   Phase 2 Clinical Trial Enrollment...
Tuesday, May 14, 2019   (0 Comments - view/add)
Unexplored neural circuit modulates memory strength »
For Immediate Release Unexplored neural circuit modulates memory strength JUPITER, Fla. – May 14, 2019 — Learn...
Thursday, May 9, 2019   (0 Comments - view/add)
New Study Shows Catalyst CSR™ Total Shoulder System Provides Improved Accuracy and Precision in Rest »
New Study Shows Catalyst CSR™ Total Shoulder System Provides Improved Accuracy and Precision in Restoring Humeral Anatomy...
Monday, May 6, 2019   (0 Comments - view/add)
HedgePath Pharmaceuticals Announces Notice of Allowability of U.S. Patent Application Regarding Trea »
HedgePath Pharmaceuticals Announces Notice of Allowability of U.S. Patent Application Regarding Treatment of Prostate Canc...
Monday, April 22, 2019   (0 Comments - view/add)
Variant Pharmaceuticals Expands Development Focus Into $60+ Billion Anti-inflammatory Market with Wo »
Variant Pharmaceuticals Expands Development Focus Into $60+ Billion Anti-inflammatory Market with Worldwide License to Nov...
Monday, April 22, 2019   (0 Comments - view/add)
Axogen, Inc. Announces Completion of Planned Interim Analysis and One-Time Enrollment Expansion for »
Axogen, Inc. Announces Completion of Planned Interim Analysis and One-Time Enrollment Expansion for RECON® Study  ...
Wednesday, April 17, 2019   (0 Comments - view/add)
ADMA Biologics Granted U.S. Patent for Treatment and Prevention of Pneumococcal Infections »
ADMA Biologics Granted U.S. Patent for Treatment and Prevention of Pneumococcal Infections Download as PDF...
Wednesday, April 17, 2019   (0 Comments - view/add)
TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S. »
TherapeuticsMD Announces Commercial Availability of BIJUVA ™ in the U.S. -BIJUVA is the only FDA-approved Therap...
Friday, April 12, 2019   (0 Comments - view/add)
OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial »
OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial   Apri...
Tuesday, April 9, 2019   (0 Comments - view/add)
FDA Approves Evenity™ (Romosozumab-Aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women A »
FDA APPROVES EVENITY™ (ROMOSOZUMAB-AQQG) FOR THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN AT HIGH RISK FOR FRACTU...
Monday, April 8, 2019   (0 Comments - view/add)
AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials »
AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials   GAINESVILLE, Fla., and CAMBRI...
Monday, April 1, 2019   (0 Comments - view/add)
FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin »
FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin   April 01, 2019 Approved for Use in th...
Wednesday, March 27, 2019   (0 Comments - view/add)
AdventHealth is the first in Florida to use state-of-the-art robotic technology for spinal procedure »
AdventHealth is the first in Florida to use state-of-the-art robotic technology for spinal procedures   M...
Thursday, March 21, 2019   (0 Comments - view/add)
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial »
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial   MIAMI, March 21, 2019 (GLOBE NE...
Wednesday, March 20, 2019   (0 Comments - view/add)
RTI Surgical Enrolls First Patient in FORTE Clinical Study of Fortilink® Interbody Fusion Device wit »
RTI Surgical Enrolls First Patient in FORTE Clinical Study of Fortilink® Interbody Fusion Device with TETRAfuse® 3D Techno...

Displaying page 1 of 7
1  |  2  |  3  |  4  |  5  |  6  |  7

About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.

 

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

 

NEW regional sponsorship opportunities available.

Connect